The Comparative One-Year Drug Survival Rate of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid arthritis and ankylosing spondylitis; results from Turkbio Registry.

Sari, IsmailKalyoncu, UmutOnat, Ahmet MesutPamuk, Omer NuriKaradag, OmerKisacik, BunyaminKrogh, Niels Steen2024-06-122024-06-1220142326-51912326-5205https://hdl.handle.net/20.500.14551/2673478th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP) -- NOV 14-19, 2014 -- Boston, MA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]The Comparative One-Year Drug Survival Rate of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid arthritis and ankylosing spondylitis; results from Turkbio Registry.Conference Object66S1120S1120Q4WOS:000344384905239